FABP2 Antikörper

Produktnummer ABIN2192186

Produktdetails anti-FABP2 Antikörper

Target: FABP2 (Fatty Acid Binding Protein 2, Intestinal (FABP2))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser FABP2 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunoassay (IA)

Kreuzreaktivität (Details): Cross reactivity: Rat I-FABP : Yes, Mouse I-FABP : Yes, Sheep I-FABP : Yes, Swine I-FABP : Yes

Sterilität: 0.2 μm filtered

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: For Immuno assay and Western blotting, dilutions to be used depend on detection system applied. It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:50.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: PBS, containing 0.1 % bovine serum albumin and 0.02 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C

Informationen zur Lagerung: Product should be stored at 4 °C. Under recommended storage conditions, product is stable for one year.

Haltbarkeit: 12 months

Referenzen für anti-FABP2 Antikörper (ABIN2192186)

Kanda, Fujii, Tani, Murakami, Suda, Sakai, Ono, Hatakeyama: "Intestinal fatty acid-binding protein is a useful diagnostic marker for mesenteric infarction in humans." in: Gastroenterology, Vol. 110, Issue 2, pp. 339-43, (1996) (PubMed).

Morrissey, Gollin, Marks: "Small bowel allograft rejection detected by serum intestinal fatty acid-binding protein is reversible." in: Transplantation, Vol. 61, Issue 10, pp. 1451-5, (1996) (PubMed).

Details zu FABP2

Target: FABP2 (Fatty Acid Binding Protein 2, Intestinal (FABP2))

Andere Bezeichnung: Intestinal Fatty Acid Binding Protein (FABP2 Produkte)

Synonyme: I-FABP antikoerper, ifabp antikoerper, zgc:92264 antikoerper, IFABP antikoerper, fabpi antikoerper, i-fabp antikoerper, fabp2-A antikoerper, FABP2 antikoerper, FABPI antikoerper, FABP antikoerper, Fabpi antikoerper, fabp2 antikoerper, fabp2a antikoerper, fatty acid binding protein 2, intestinal antikoerper, fatty acid binding protein 2 antikoerper, fatty acid binding protein 2 L homeolog antikoerper, fabp2 antikoerper, FABP2 antikoerper, Fabp2 antikoerper, fabp2.L antikoerper

Hintergrund: The polyclonal antibody recognizes human intestinal fatty acid binding protein (I-FABP) of both natural and recombinant origin. The I-FABP protein is derived from the human FABP2 gene. FABPs are small intracellular proteins (~13-14 kDa) with a high degree of tissue specificity that bind long chain fatty acids. They are abundantly present in various cell types and play an important role in the intracellular utilization of fatty acids, transport and metabolism. There are at least nine distinct types of FABP, each showing a specific pattern of tissue expression. Due to its small size, FABP leaks rapidly out of ischemically damaged necrotic cells leading to a rise in serum levels. Ischemically damaged tissues are characterized histologically by absence (or low presence) of FABP facilitating recognition of such areas. I-FABP is localized in the small bowel epithelium, with highest expression level in the jejunum. Aliases FABP2, FABPI